Non-artificial human in vitro skin tests

The Skimune^® platform (Skimune^®Cosm; Skimune^®Chem; Skimune^®Mab) are unique non-artificial human in vitro skin tests

The Skimune^® platform predicts hypersensitivity responses to pharmaceuticals including small molecule drugs and monoclonal antibodies, chemicals and cosmetics

Skimune^® provides a pre-clinical predictive readout of skin damage which correlates with screening assays ie. cytokine release and T cell proliferation

Skimune^®Mab is the only commercially available test for predicting adverse immune reactions to monoclonal antibodies, biobetters, biosimilars and antibody drug conjugates

The Skimune^® platform tests are also used in dose response and efficacy studies for immunomodulatory drugs prior to Phase One clinical trials

The Skimune^® 3D high throughput screening for the detection of sensitisation and toxicity to drugs, chemicals and cosmetics

A pre-clinical/clinical service tool. It is designed to predict first in-man adverse immune or allergic responses to new therapeutics.

Find out more

A safety assessment tool for testing cosmetics or household products.

Find out more

A human in vitro skin explant assay which detects activation of immune cells (T-lymphocytes) by antigen presenting cells.

Find out more

3D skin assay for the detection of toxicity and adverse immune reactions.

Find out more

About Us

Alcyomics offers human in vitro (lab-based) pre-clinical safety testing to ensure drug safety and efficacy before first administration into man.

If the Alcyomics Skimune^® technology had been available the Northwick Park drug trial disaster, which resulted in catastrophic systemic organ failure in human subjects would have been averted.

Immunogenicity testing of cellular therapies.

Keeping you updated on all news and events.

Anne’s research at Newcastle University led to the founding of Alcyomics in 2007. Due to her expertise in immunobiology she has developed human skin based in vitro assays for predicting clinical responses prior to clinical trial.

Dr Shaheda Ahmed

Scientific Manager

Shaheda’s expertise includes cell and molecular biology and human skin explant assay technology.